The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease

被引:0
|
作者
Hlin Kvartsberg
Tammaryn Lashley
Christina E. Murray
Gunnar Brinkmalm
Nicholas C. Cullen
Kina Höglund
Henrik Zetterberg
Kaj Blennow
Erik Portelius
机构
[1] The Sahlgrenska Academy at the University of Gothenburg,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology
[2] Sahlgrenska University Hospital/Mölndal,Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders
[3] UCL Institute of Neurology,Department of Neurodegenerative Disease
[4] UCL Institute of Neurology,Clinical Neurochemistry Laboratory
[5] UK Dementia Research Institute at UCL,Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Disease Research, Neurogeriatrics Division
[6] Sahlgrenska University Hospital,undefined
[7] Karolinska Institutet,undefined
来源
Acta Neuropathologica | 2019年 / 137卷
关键词
Neurogranin; Alzheimer’s disease; Brain tissue; Familial Alzheimer’s disease; Mass spectrometry;
D O I
暂无
中图分类号
学科分类号
摘要
Synaptic degeneration and neuronal loss are early events in Alzheimer’s disease (AD), occurring long before symptom onset, thus making synaptic biomarkers relevant for enabling early diagnosis. The postsynaptic protein neurogranin (Ng) is a cerebrospinal fluid (CSF) biomarker for AD, also in the prodromal phase. Here we tested the hypothesis that during AD neurodegeneration, processing of full-length Ng into endogenous peptides in the brain is increased. We characterized Ng in post-mortem brain tissue and investigated the levels of endogenous Ng peptides in relation to full-length protein in brain tissue of patients with sporadic (sAD) and familial Alzheimer’s disease (fAD), healthy controls and individuals who were cognitively unaffected but amyloid-positive (CU-AP) in two different brain regions. Brain tissue from parietal cortex [sAD (n = 10) and age-matched controls (n = 10)] and temporal cortex [sAD (n = 9), fAD (n = 10), CU-AP (n = 13) and controls (n = 9)] were included and all the samples were analyzed by three different methods. Using high-resolution mass spectrometry, 39 endogenous Ng peptides were identified while full-length Ng was found to be modified including disulfide bridges or glutathione. In sAD parietal cortex, the ratio of peptide-to-total full-length Ng was significantly increased for eight endogenous Ng peptides compared to controls. In the temporal cortex, several of the peptide-to-total full-length Ng ratios were increased in both sAD and fAD cases compared to controls and CU-AP. This finding was confirmed by western blot, which mainly detects full-length Ng, and enzyme-linked immunosorbent assay, most likely detecting a mix of peptides and full-length Ng. In addition, Ng was significantly associated with the degree of amyloid and tau pathology. These results suggest that processing of Ng into peptides is increased in AD brain tissue, which may reflect the ongoing synaptic degeneration, and which is also mirrored as increased levels of Ng peptides in CSF.
引用
收藏
页码:89 / 102
页数:13
相关论文
共 50 条
  • [21] Polymicrobial Infections In Brain Tissue From Alzheimer's Disease Patients
    Pisa, Diana
    Alonso, Ruth
    Fernandez-Fernandez, Ana M.
    Rabano, Alberto
    Carrasco, Luis
    SCIENTIFIC REPORTS, 2017, 7
  • [22] Polymicrobial Infections In Brain Tissue From Alzheimer’s Disease Patients
    Diana Pisa
    Ruth Alonso
    Ana M. Fernández-Fernández
    Alberto Rábano
    Luis Carrasco
    Scientific Reports, 7
  • [23] Sporadic Alzheimer's Disease: The Starving Brain
    Mamelak, Mortimer
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (03) : 459 - 474
  • [24] Cell cycle regulation in immortalized lymphocytes differentiate sporadic from familial Alzheimer’s disease patients
    Emilia Białopiotrowicz
    Bożena Kuźniewska
    Neli Kachamakova-Trojanowska
    Jacek Kuźnicki
    Urszula Wojda
    Pharmacological Reports, 2009, 61 (6) : 1224 - 1225
  • [25] Cell cycle regulation in immortalized lymphocytes differentiate sporadic from familial Alzheimer's disease patients
    Bialopiotrowicz, Emilia
    Kuzniewska, Bozena
    Kachamakova-Trojanowska, Neli
    Kuznicki, Jacek
    Wojda, Urszula
    PHARMACOLOGICAL REPORTS, 2009, 61 (06) : 1224 - 1225
  • [26] Brain imaging evidence of early involvement of subcortical regions in familial and sporadic Alzheimer's disease
    Tentolouris-Piperas, Vasileios
    Ryan, Natalie S.
    Thomas, David L.
    Kinnunen, Kirsi M.
    BRAIN RESEARCH, 2017, 1655 : 23 - 32
  • [27] Molecular pathogenesis of sporadic and familial forms of Alzheimer's disease
    Ray, WJ
    Ashall, F
    Goate, AM
    MOLECULAR MEDICINE TODAY, 1998, 4 (04): : 151 - 157
  • [28] Aβ38 in the Brains of Patients with Sporadic and Familial Alzheimer's Disease and Transgenic Mouse Models
    Reinert, Jochim
    Martens, Henrik
    Huettenrauch, Melanie
    Kolbow, Tekla
    Lannfelt, Lars
    Ingelsson, Martin
    Paetau, Anders
    Verkkoniemi-Ahola, Auli
    Bayer, Thomas A.
    Wirths, Oliver
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 39 (04) : 871 - 881
  • [29] Protein kinase C and amyloid precursor protein processing in skin fibroblasts from sporadic and familial Alzheimer's disease cases
    Vestling, M
    Cedazo-Mínguez, A
    Adem, A
    Wiehager, B
    Racchi, M
    Lannfelt, L
    Cowburn, RF
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1999, 1453 (03): : 341 - 350
  • [30] Overexpression of calsenilin in sporadic Alzheimer's disease brain
    Jin, JK
    Choi, JK
    Kim, JI
    Lee, HG
    Wasco, W
    Buxbaum, JD
    Carp, RI
    Kim, YS
    Choi, EK
    HEALTHY AGING FOR FUNCTIONAL LONGEVITY: MOLECULAR AND CELLULAR INTERACTIONS IN SENESCENCE, 2001, 928 : 373 - 373